Screening Assay for Inhibitors of Severe Acute Respiratory Syndrome (SARS) Using SELDI-TOF Mass Spectrometry

Authors

Khalid M. Elased, Wright State University - Main CampusFollow
Mariana MorrisFollow

Document Type

Patent

Publication Date

11-16-2006

Abstract

Mass spectrometric methods directed to screening libraries of compounds for agents that inhibit entry of Severe Acute Respiratory Syndrome (SARS) coronavirus (CoV) into cells are provided, along with methods for comparatively evaluating inhibitors of the SARS CoV.

Comments

United States Patent Application US20060257861 A1

Repository Citation

Elased, K. M., & Morris, M. (2006). Screening Assay for Inhibitors of Severe Acute Respiratory Syndrome (SARS) Using SELDI-TOF Mass Spectrometry. .
https://corescholar.libraries.wright.edu/ptox/145